GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » FCF Yield %

Vectus Biosystems (ASX:VBS) FCF Yield % : -27.34 (As of Jul. 26, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Vectus Biosystems FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Vectus Biosystems's Trailing 12-Month Free Cash Flow is A$-1.38 Mil, and Market Cap is A$5.06 Mil. Therefore, Vectus Biosystems's FCF Yield % for today is -27.34%.

The historical rank and industry rank for Vectus Biosystems's FCF Yield % or its related term are showing as below:

ASX:VBS' s FCF Yield % Range Over the Past 10 Years
Min: -34.17   Med: 0   Max: 0
Current: -27.34


ASX:VBS's FCF Yield % is ranked worse than
66.1% of 1531 companies
in the Biotechnology industry
Industry Median: -13.28 vs ASX:VBS: -27.34

Vectus Biosystems's FCF Margin % for the quarter that ended in Dec. 2023 was -86,200.00%.


Vectus Biosystems FCF Yield % Historical Data

The historical data trend for Vectus Biosystems's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems FCF Yield % Chart

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
FCF Yield %
Get a 7-Day Free Trial -13.10 -17.63 -7.62 -12.49 -10.13

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.70 -12.53 -9.53 -4.44 -10.80

Competitive Comparison of Vectus Biosystems's FCF Yield %

For the Biotechnology subindustry, Vectus Biosystems's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectus Biosystems's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's FCF Yield % falls into.



Vectus Biosystems FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Vectus Biosystems's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-2.37 / 23.40338
=-10.13%

Vectus Biosystems's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.862 * 2 / 15.96282
=-10.80%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vectus Biosystems FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Vectus Biosystems FCF Yield % Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectus Biosystems Business Description

Traded in Other Exchanges
N/A
Address
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems Headlines

No Headlines